BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 34617042)

  • 1. Corrugated nanofiber tissue-engineered vascular graft to prevent kinking for arteriovenous shunts in an ovine model.
    Matsushita H; Inoue T; Abdollahi S; Yeung E; Ong CS; Lui C; Pitaktong I; Nelson K; Johnson J; Hibino N
    JVS Vasc Sci; 2020; 1():100-108. PubMed ID: 34617042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel reinforcement of corrugated nanofiber tissue-engineered vascular graft to prevent aneurysm formation for arteriovenous shunts in an ovine model.
    Matsushita H; Hayashi H; Nurminsky K; Dunn T; He Y; Pitaktong I; Koda Y; Xu S; Nguyen V; Inoue T; Rodgers D; Nelson K; Johnson J; Hibino N
    JVS Vasc Sci; 2022; 3():182-191. PubMed ID: 35495567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue-Engineered Small Diameter Arterial Vascular Grafts from Cell-Free Nanofiber PCL/Chitosan Scaffolds in a Sheep Model.
    Fukunishi T; Best CA; Sugiura T; Shoji T; Yi T; Udelsman B; Ohst D; Ong CS; Zhang H; Shinoka T; Breuer CK; Johnson J; Hibino N
    PLoS One; 2016; 11(7):e0158555. PubMed ID: 27467821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential outcomes of venous and arterial tissue engineered vascular grafts highlight the importance of coupling long-term implantation studies with computational modeling.
    Best CA; Szafron JM; Rocco KA; Zbinden J; Dean EW; Maxfield MW; Kurobe H; Tara S; Bagi PS; Udelsman BV; Khosravi R; Yi T; Shinoka T; Humphrey JD; Breuer CK
    Acta Biomater; 2019 Aug; 94():183-194. PubMed ID: 31200116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical study of patient-specific cell-free nanofiber tissue-engineered vascular grafts using 3-dimensional printing in a sheep model.
    Fukunishi T; Best CA; Sugiura T; Opfermann J; Ong CS; Shinoka T; Breuer CK; Krieger A; Johnson J; Hibino N
    J Thorac Cardiovasc Surg; 2017 Apr; 153(4):924-932. PubMed ID: 27938900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of pore diameter on neo-tissue formation in electrospun biodegradable tissue-engineered arterial grafts in a large animal model.
    Matsuzaki Y; Iwaki R; Reinhardt JW; Chang YC; Miyamoto S; Kelly J; Zbinden J; Blum K; Mirhaidari G; Ulziibayar A; Shoji T; Breuer CK; Shinoka T
    Acta Biomater; 2020 Oct; 115():176-184. PubMed ID: 32822820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of a Novel Small-diameter Tissue-engineered Arterial Graft With Heparin Conjugation.
    Matsuzaki Y; Miyamoto S; Miyachi H; Iwaki R; Shoji T; Blum K; Chang YC; Kelly J; Reinhardt JW; Nakayama H; Breuer CK; Shinoka T
    Ann Thorac Surg; 2021 Apr; 111(4):1234-1241. PubMed ID: 32946845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fast-Degrading Tissue-Engineered Vascular Grafts Lead to Increased Extracellular Matrix Cross-Linking Enzyme Expression.
    Fukunishi T; Ong CS; He YJ; Inoue T; Zhang H; Steppan J; Matsushita H; Johnson J; Santhanam L; Hibino N
    Tissue Eng Part A; 2021 Nov; 27(21-22):1368-1375. PubMed ID: 33599167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bilateral Arteriovenous Shunts as a Method for Evaluating Tissue-Engineered Vascular Grafts in Large Animal Models.
    Ong CS; Fukunishi T; Liu RH; Nelson K; Zhang H; Wieczorek E; Palmieri M; Ueyama Y; Ferris E; Geist GE; Youngblood B; Johnson J; Hibino N
    Tissue Eng Part C Methods; 2017 Nov; 23(11):728-735. PubMed ID: 28741438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and in vivo evaluation of small-diameter vascular grafts engineered by outgrowth endothelial cells and electrospun chitosan/poly(ε-caprolactone) nanofibrous scaffolds.
    Zhou M; Qiao W; Liu Z; Shang T; Qiao T; Mao C; Liu C
    Tissue Eng Part A; 2014 Jan; 20(1-2):79-91. PubMed ID: 23902162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced patency in left-sided arteriovenous grafts in a porcine model.
    Liu S; Wang T; Wang J; Isaji T; Ono S; Fereydooni A; Taniguchi R; Matsubara Y; Niklason LE; Dardik A
    J Vasc Surg; 2020 Jul; 72(1):305-317.e6. PubMed ID: 31699515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Porcine carotid artery replacement with biodegradable electrospun poly-e-caprolactone vascular prosthesis.
    Mrówczyński W; Mugnai D; de Valence S; Tille JC; Khabiri E; Cikirikcioglu M; Möller M; Walpoth BH
    J Vasc Surg; 2014 Jan; 59(1):210-9. PubMed ID: 23707057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction of an autologous tissue-engineered venous conduit from bone marrow-derived vascular cells: optimization of cell harvest and seeding techniques.
    Roh JD; Brennan MP; Lopez-Soler RI; Fong PM; Goyal A; Dardik A; Breuer CK
    J Pediatr Surg; 2007 Jan; 42(1):198-202. PubMed ID: 17208565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioengineered vascular access maintains structural integrity in response to arteriovenous flow and repeated needle puncture.
    Tillman BW; Yazdani SK; Neff LP; Corriere MA; Christ GJ; Soker S; Atala A; Geary RL; Yoo JJ
    J Vasc Surg; 2012 Sep; 56(3):783-93. PubMed ID: 22917043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled and Synchronised Vascular Regeneration upon the Implantation of Iloprost- and Cationic Amphiphilic Drugs-Conjugated Tissue-Engineered Vascular Grafts into the Ovine Carotid Artery: A Proteomics-Empowered Study.
    Antonova L; Kutikhin A; Sevostianova V; Lobov A; Repkin E; Krivkina E; Velikanova E; Mironov A; Mukhamadiyarov R; Senokosova E; Khanova M; Shishkova D; Markova V; Barbarash L
    Polymers (Basel); 2022 Nov; 14(23):. PubMed ID: 36501545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue-engineered vascular grafts demonstrate evidence of growth and development when implanted in a juvenile animal model.
    Brennan MP; Dardik A; Hibino N; Roh JD; Nelson GN; Papademitris X; Shinoka T; Breuer CK
    Ann Surg; 2008 Sep; 248(3):370-7. PubMed ID: 18791357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of remodeling process in small-diameter cell-free tissue-engineered arterial graft.
    Tara S; Kurobe H; Maxfield MW; Rocco KA; Yi T; Naito Y; Breuer CK; Shinoka T
    J Vasc Surg; 2015 Sep; 62(3):734-43. PubMed ID: 24745941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue-engineered blood vessels with endothelial nitric oxide synthase activity.
    Lim SH; Cho SW; Park JC; Jeon O; Lim JM; Kim SS; Kim BS
    J Biomed Mater Res B Appl Biomater; 2008 May; 85(2):537-46. PubMed ID: 18076094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical
    Atari M; Saroukhani A; Manshaei M; Bateni P; Zargar Kharazi A; Vatankhah E; Haghjooy Javanmard S
    Biomater Sci; 2023 Oct; 11(20):6871-6880. PubMed ID: 37646468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An early study on the mechanisms that allow tissue-engineered vascular grafts to resist intimal hyperplasia.
    Prichard HL; Manson RJ; DiBernardo L; Niklason LE; Lawson JH; Dahl SL
    J Cardiovasc Transl Res; 2011 Oct; 4(5):674-82. PubMed ID: 21748530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.